Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi Post author:Sam Post published:January 31, 2018 Post category:BioPharma Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace You Might Also Like Boy Wonder Roivant Bets $116 Million on Arbutus October 1, 2017 Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents November 21, 2017 Tiny New York Biotech With Ties To Massachusetts, Syntimmune, Gets A $50 Million Boost June 20, 2017